SOUTH SAN FRANCISCO, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $58.4 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.29.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.

Atara Biotherapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.

—————

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.